Current and emerging surrogate markers of hepatic fibrosis in primary biliary cirrhosis

Liver International

Volumn 28, Issue 6, 2008, Pages 761-763

  Talwalkar, Jayant A ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; BILE ACID; BILIRUBIN; BUDESONIDE; HYALURONIC ACID; PLACEBO; PROCOLLAGEN TYPE 3 AMINOPROPEPTIDE; URSODEOXYCHOLIC ACID;

CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DISEASE COURSE; EDITORIAL; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER FAILURE; LIVER FIBROSIS; PRIMARY BILIARY CIRRHOSIS; PROGNOSIS; SENSITIVITY AND SPECIFICITY; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

BIOLOGICAL MARKERS; DISEASE PROGRESSION; HUMANS; LIVER; LIVER CIRRHOSIS; LIVER CIRRHOSIS, BILIARY;

EID: 44949263921     PISSN: 14783223     EISSN: 14783231     Source Type: Journal    
DOI: 10.1111/j.1478-3231.2008.01761.x     Document Type: Editorial

References (19)

1. Talwalkar JA, Lindor KD. Primary biliary cirrhosis. Lancet 2003; 362: 53-61.
2. Poupon RE, Lindor KD, Parés A, et al. Combined analysis of the effect of treatment with ursodeoxycholic acid on histologic progression in primary biliary cirrhosis. J Hepatol 2003; 39: 12-6.
3. Degott C, Zafrani ES, Callard P, et al. Histopathological study of primary biliary cirrhosis and the effect of ursodeoxycholic acid treatment on histology progression. Hepatology 1999; 29: 1007-12.
4. Zein CO, Angulo P, Lindor KD. When is liver biopsy needed in the diagnosis of primary biliary cirrhosis? Clin Gastroenterol Hepatol 2003; 1: 89-95.
5. Garrido MC, Hubscher SG. Accuracy of staging in primary biliary cirrhosis. J Clin Pathol 1996; 49: 556-9.
6. Standish RA, Cholongitas E, Dhillon A, et al. An appraisal of the histopathological assessment of liver fibrosis. Gut 2006; 55: 569-78.
7. Corpechot C, Carrat F, Poupon R, et al. Primary biliary cirrhosis: incidence and predictive factors of cirrhosis development in ursodiol-treated patients. Gastroenterology 2002; 122: 652-8.
8. Corpechot C, Poujol-Robert A, Wendum D, et al. Biochemical markers of liver fibrosis and lymphocytic piecemeal necrosis in UDCA-treated patients with primary biliary cirrhosis. Liver Int 2004; 24: 187-93.
9. Nyberg A, Engström-Laurent A, Lööf L. Serum hyaluronate in primary biliary cirrhosis - a biochemical marker for progressive liver damage. Hepatology 1988; 8: 142-6.
10. Guéchot J, Poupon RE, Giral P, et al. Relationship between procollagen III aminoterminal propeptide and hyaluronan serum levels and histological fibrosis in primary biliary cirrhosis and chronic viral hepatitis C. J Hepatol 1994; 20: 388-93.
11. Nyblom H, Björnsson E, Simrén M, et al. The AST/ALT ratio as an indicator of cirrhosis in patients with PBC. Liver Int 2006; 26: 840-5.
12. Rockey DC, Bissell DM. Noninvasive measures of liver fibrosis. Hepatology 2006; 43(2 Suppl 1): S113-20.
13. Parkes J, Mayo M, Cross R, et al. European Liver Fibrosis (ELF) markers accurately distinguish fibrosis severity in primary biliary cirrhosis; an external validation study. Hepatology 2006; 44(4 Suppl 2): 629A.
14. Farkkila M, Rautiainen H, Kärkkäinen P, et al. Serological markers for monitoring disease progression in non-cirrhotic PBC on UDCA therapy. Liver Int 2008; 28: 787-97.
15. Rautiainen H, Kärkkäinen P, Karvonen AL, et al. Budesonide combined with UDCA to improve liver histology in primary biliary cirrhosis: A three-year randomized trial. Hepatology 2005; 41: 747-52.
16. Corpechot C, El Naggar A, Poujol-Robert A, et al. Assessment of biliary fibrosis by transient elastography in patients with PBC and PSC. Hepatology 2006; 43: 1118-24.
17. Gómez-Dominguez E, Mendoza J, García-Buey L, et al. Transient elastography to assess hepatic fibrosis in primary biliary cirrhosis. Aliment Pharmacol Ther 2008; 27: 441-7.
18. Yin M, Talwalkar JA, Glaser KJ, et al. Assessment of hepatic fibrosis with magnetic resonance elastography. Clin Gastroenterol Hepatol 2007; 5: 1207-13.
19. Medina J, Sanz-Cameno P, García-Buey L, et al. Evidence of angiogenesis in primary biliary cirrhosis: An immunohistochemical descriptive study. J Hepatol 2005; 42: 124-31.